In this issue of Journal of Diabetes Science and Technology, Davey and coauthors present encouraging data that even short-term use of a real-time continuous glucose monitor can lead to marked reduction in hypoglycemia exposure. In this analysis, two particular issues will be discussed: The distinction between short- and long-term experiences with sensors and the use of standardized diabetes treatment algorithms for use with continuous glucose monitoring (CGM) devices. An understanding of both of these aspects of CGM devices is necessary for placing clinical diabetes technology products into the context of how they will be used in “real life.”
HirschIBAbelsethJBodeBWFischerJSKaufmanFRMastrototaroJParkinCGWolpertHABuckinghamBA. Sensor-augmented insulin pump therapy: Results of the first randomized treat-to-target study. Diabetes Technol Ther.2008; 10 (5): 377–83.
2.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med.;2008; 359 (14): 1464–76.
3.
BergenstalRMTamborlaneWVAhmannABuseJBDaileyGDavisSNJoyceCPeoplesTPerkinsBAWelshJBWilliSMWoodMA; STAR 3 Study Group. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med.2010; 363 (11): 311–20.
4.
DaveyRJJonesTWFournierPA. Effect of short term use of a continuous glucose monitoring system with a real-time glucose display and a low glucose alarm on incidence and duration of hypoglycemia in a home setting in type 1 diabetes mellitus. J Diabetes Sci Technol.2010; 4 (6): 1457–64.
5.
Diabetes Research in Children Network (DirecNet) Study Group, Buckingham B, Beck RW, Tamborlane WV, Xing D, Kollman C, Fiallo-Scharer R, Mauras N, Ruedy KJ, Tansey M, Weinzimer SA, Wysocki T. Continuous glucose monitoring in children with type 1 diabetes. J Pediatr.;2007; 151 (4): 388–93, 393.e1–2. Epub 2007 Aug 24.
6.
WeinzimerSXingDTanseyMFiallo-ScharerRMaurasNWysockiTBeckRTamborlaneWRuedyK; Diabetes Research in Children Network (DirecNet) Study Group. FreeStyle Navigator continuous glucose monitoring system use in children with type 1 diabetes using glargine-based multiple daily dose regimens: Results of a pilot trial Diabetes Research in Children Network (DirecNet) Study Group. Diabetes Care.2008; 31 (3): 525–7.
7.
Diabetes Research In Children Network (DirecNet) Study Group, Buckingham B, Xing D, Weinzimer S, Fiallo-Scharer R, Kollman C, Mauras N, Tsalikian E, Tamborlane W, Wysocki T, Ruedy K, Beck R. Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator). Pediatr Diabetes.;2008; 9 (2): 142–7.
8.
MesserLRuedyKXingDCoffeyJEnglertKCaswellKIvesB. Educating families on real time continuous glucose monitoring: The DirecNet Navigator pilot study experience. Diabetes Educ.2009; 35: 124–35.
9.
BequetteBW. Continuous glucose monitoring: Real-time algorithms for calibration, filtering, and alarms. J Diabetes Sci Technol.2010; 4 (2): 404–18.
10.
DassauECameronFLeeHBequetteBWZisserHJovanovicLChaseHPWilsonDMBuckinghamBADoyleFJ3rd. Real-time hypoglycemia prediction suite using continuous glucose monitoring: A safety net for the artificial pancreas. Diabetes Care.2010; 33 (6): 1249–54.
11.
BuckinghamBChaseHPDassauECobryEClintonPGageVCaswellKWilkinsonJCameronFLeeHBequetteBWDoyleFJ3rd. Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Care.2010; 33 (5): 1013–7.
